1.Is cerebral cavernous malformation a pre-glioma lesion?
Ji-yang ZHANG ; Zong-yi MING ; An-hua WU
Chinese Medical Journal 2012;125(24):4511-4513
Glioma is the most malignant tumor in the brain, the origin of glioma is still unknown. Recently some papers indicated that glioma may be developed from cerebral cavernous malformation (CCM). We describe a man with a right temporal lobe CCM, after gamma-knife radiotherapy, the patient developed a low-grade astrocytoma in the area of the preexistent CCM. This case, together with other reports, may indicated an oncogenetic properties of CCM, and we proposed that CCM may be a pre-glioma lesion.
Glioma
;
diagnostic imaging
;
pathology
;
Hemangioma, Cavernous, Central Nervous System
;
diagnostic imaging
;
pathology
;
Humans
;
Male
;
Radiography
2.An artificial neural network model for glioma grading using image information.
Yitao MAO ; Weihua LIAO ; Dong CAO ; Luqing ZHAO ; Xunhua WU ; Lingyu KONG ; Gaofeng ZHOU ; Yuelong ZHAO ; Dongcui WANG
Journal of Central South University(Medical Sciences) 2018;43(12):1315-1322
To explore the feasibility and efficacy of artificial neural network for differentiating high-grade glioma and low-grade glioma using image information.
Methods: A total of 130 glioma patients with confirmed pathological diagnosis were selected retrospectively from 2012 to 2017. Forty one imaging features were extracted from each subjects based on 2-dimension magnetic resonance T1 weighted imaging with contrast-enhancement. An artificial neural network model was created and optimized according to the performance of feature selection. The training dataset was randomly selected half of the whole dataset, and the other half dataset was used to verify the performance of the neural network for glioma grading. The training-verification process was repeated for 100 times and the performance was averaged.
Results: A total of 5 imaging features were selected as the ultimate input features for the neural network. The mean accuracy of the neural network for glioma grading was 90.32%, with a mean sensitivity at 87.86% and a mean specificity at 92.49%. The area under the curve of receiver operating characteristic curve was 0.9486.
Conclusion: As a technique of artificial intelligence, neural network can reach a relatively high accuracy for the grading of glioma and provide a non-invasive and promising computer-aided diagnostic process for the pre-operative grading of glioma.
Brain Neoplasms
;
diagnostic imaging
;
pathology
;
Glioma
;
diagnostic imaging
;
pathology
;
Humans
;
Magnetic Resonance Imaging
;
Neoplasm Grading
;
Neural Networks, Computer
;
ROC Curve
;
Retrospective Studies
;
Sensitivity and Specificity
3.Tuberous sclerosis complex: Imaging characteristics in 11 cases and review of the literature.
Shan HU ; Dao-Yu HU ; Wen-Zhen ZHU ; Liang WANG ; Zi WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(4):601-606
Tuberous sclerosis complex (TSC) is an uncommon multiorgan disorder that may present many and different manifestations on imaging. Radiology plays an important role in diagnosis and management, and can substantially improve the clinical outcome of TSC. Therefore, a comprehensive understanding of this disease is essential for the radiologist. The manifestations of TSC on computer tomography (CT) and magnetic resonance (MR) images were analyzed. Eleven patients with a clinical diagnosis of TSC were retrospectively reviewed. Central nervous system lesions included subependymal nodules (SENs) (11/11), subependymal giant cell astrocytomas (SEGAs) (2/11), cortical and subcortical tuber lesions (5/11), and white matter lesions (4/11). Of the 6 patients with abdominal scans, there were 6 cases of renal angiomyolipomas (AMLs), and one case of hepatic AMLs. Of the 4 patients undergoing chest CT, lung lymhangioleiomyomatosis (LAM) (2/4), and multiple small sclerotic bone lesions (2/4) were observed. Different modalities show different sensitivity to the lesion. Analysis of images should be integrated with patients' history in order to diagnose TSC.
Adolescent
;
Adult
;
Brain
;
diagnostic imaging
;
pathology
;
Child
;
Child, Preschool
;
Female
;
Glioma, Subependymal
;
diagnosis
;
diagnostic imaging
;
pathology
;
Humans
;
Lung
;
diagnostic imaging
;
pathology
;
Magnetic Resonance Imaging
;
methods
;
Male
;
Middle Aged
;
Nervous System Diseases
;
diagnosis
;
diagnostic imaging
;
pathology
;
Tuberous Sclerosis
;
classification
;
diagnosis
;
diagnostic imaging
;
pathology
4.Clinicopathologic characteristics and microsurgical treatment of glioma of limbic and paralimbic system.
Meng LIU ; Yu-guang LIU ; Liang-wen ZHANG ; Hong-wei WANG ; Shu-gan ZHU ; Cheng-yuan WU
Chinese Journal of Surgery 2005;43(13):882-884
OBJECTIVETo explore the features of the clinical manifestations, imaging, pathology and microsurgery on the patients with gliomas of limbic and paralimbic system.
METHODSThe clinical data of 28 patients with gliomas of limbic and paralimbic system were analyzed respectively.
RESULTSSeizure was the most common symptom, presented in 24 cases. CT scans showed hypodensity in 19 cases and isodensity in 9 cases. MRI scans were achieved in 23 cases, showing hypointense signal on T(1)WI and hyperintense signal on T(2)WI. Total resection was achieved in 19 cases, subtotal in 6 cases and partial in 3 cases. All patients had excellent postoperative recovery, except 5 patients who developed temporary frontal aphasia and 6 patients who developed contralateral hemiplegia. The patients had a postoperative follow-up ranging from 6 months to 5 years, and 23 cases still survived.
CONCLUSIONHigh-resolution CT and MRI may reveal the size, location, confines and sharp demarcation of the tumors. Gliomas can be microsurgically removed with considerable results.
Adolescent ; Adult ; Brain Neoplasms ; diagnostic imaging ; pathology ; surgery ; Child ; Female ; Glioma ; diagnostic imaging ; pathology ; surgery ; Humans ; Limbic System ; Magnetic Resonance Imaging ; Male ; Microsurgery ; Middle Aged ; Tomography, X-Ray Computed
5.The Effectiveness of Ferritin as a Contrast Agent for Cell Tracking MRI in Mouse Cancer Models.
Chan Wha LEE ; Sun Il CHOI ; Sang Jin LEE ; Young Taek OH ; Gunwoo PARK ; Na Yeon PARK ; Kyoung Ah YOON ; Sunshin KIM ; Daehong KIM ; Yun Hee KIM ; Jin Suck SUH
Yonsei Medical Journal 2017;58(1):51-58
PURPOSE: We aimed to investigate the effectiveness of ferritin as a contrast agent and a potential reporter gene for tracking tumor cells or macrophages in mouse cancer models. MATERIALS AND METHODS: Adenoviral human ferritin heavy chain (Ad-hFTH) was administrated to orthotopic glioma models and subcutaneous colon cancer mouse models using U87MG and HCT116 cells, respectively. Brain MR images were acquired before and daily for up to 6 days after the intracranial injection of Ad-hFTH. In the HCT116 tumor model, MR examinations were performed before and at 6, 24, and 48 h after intratumoral injection of Ad-hFTH, as well as before and every two days after intravenous injection of ferritin-labeled macrophages. The contrast effect of ferritin in vitro was measured by MR imaging of cell pellets. MRI examinations using a 7T MR scanner comprised a T1-weighted (T1w) spin-echo sequence, T2-weighted (T2w) relaxation enhancement sequence, and T2*-weighted (T2*w) fast low angle shot sequence. RESULTS: Cell pellet imaging of Ad-hFTH in vitro showed a strong negatively enhanced contrast in T2w and T2*w images, presenting with darker signal intensity in high concentrations of Fe. T2w images of glioma and subcutaneous HCT116 tumor models showed a dark signal intensity around or within the Ad-hFTH tumor, which was distinct with time and apparent in T2*w images. After injection of ferritin-labeled macrophages, negative contrast enhancement was identified within the tumor. CONCLUSION: Ferritin could be a good candidate as an endogenous MR contrast agent and a potential reporter gene that is capable of maintaining cell labeling stability and cellular safety.
Animals
;
Brain Neoplasms/*diagnostic imaging/pathology
;
Cell Line, Tumor
;
Cell Tracking/*methods
;
Colonic Neoplasms/*diagnostic imaging/pathology
;
*Contrast Media/administration & dosage
;
Disease Models, Animal
;
Female
;
*Ferritins/administration & dosage
;
Genes, Reporter
;
Glioma/*diagnostic imaging/pathology
;
Humans
;
Injections, Intravenous
;
Macrophages
;
Magnetic Resonance Imaging/*methods
;
Male
;
Mice
;
Neoplasm Transplantation
;
Skin Neoplasms/*diagnostic imaging/pathology
;
Time Factors
6.Glioma Grading Capability: Comparisons among Parameters from Dynamic Contrast-Enhanced MRI and ADC Value on DWI.
Hyun Seok CHOI ; Ah Hyun KIM ; Sung Soo AHN ; Na Young SHIN ; Jinna KIM ; Seung Koo LEE
Korean Journal of Radiology 2013;14(3):487-492
OBJECTIVE: Permeability parameters from dynamic contrast-enhanced MRI (DCE-MRI) and apparent diffusion coefficient (ADC) value on diffusion-weighted imaging (DWI) can be quantitative physiologic metrics for gliomas. The transfer constant (Ktrans) has shown efficacy in grading gliomas. Volume fraction of extravascular extracellular space (ve) has been underutilized to grade gliomas. The purpose of this study was to evaluate ve in its ability to grade gliomas and to assess the correlation with other permeability parameters and ADC values. MATERIALS AND METHODS: A total of 33 patients diagnosed with pathologically-confirmed gliomas were examined by 3 T MRI including DCE-MRI and ADC map. A region of interest analyses for permeability parameters from DCE-MRI and ADC were performed on the enhancing solid portion of the tumors. Permeability parameters form DCE-MRI and ADC between low- and high-grade gliomas; the diagnostic performances of presumptive metrics and correlation among those metrics were statistically analyzed. RESULTS: High-grade gliomas showed higher Ktrans (0.050 vs. 0.010 in median value, p = 0.002) and higher ve (0.170 vs. 0.015 in median value, p = 0.001) than low-grade gliomas. Receiver operating characteristic curve analysis showed significance in both Ktrans and ve for glioma grading. However, there was no significant difference in diagnostic performance between Ktrans and ve. ADC value did not correlate with any of the permeability parameters from DCE-MRI. CONCLUSION: Extravascular extracellular space (ve) appears to be comparable with transfer constant (Ktrans) in differentiating high-grade gliomas from low-grade gliomas. ADC value does not show correlation with any permeability parameters from DCE-MRI.
Adult
;
Aged
;
Brain Neoplasms/metabolism/*pathology
;
Contrast Media/*diagnostic use
;
Diffusion Magnetic Resonance Imaging/*methods
;
Extracellular Space/metabolism
;
Female
;
Glioma/metabolism/*pathology
;
Humans
;
Magnetic Resonance Imaging/methods
;
Male
;
Middle Aged
;
Neoplasm Grading
;
Permeability
;
ROC Curve
;
Sensitivity and Specificity
7.Clinicopathologic features of delayed radiation-induced brain injury after radiotherapy for brain tumor.
Xing-fu WANG ; Sheng ZHANG ; Yu-hong YE ; Yu-peng CHEN ; Xue-yong LIU
Chinese Journal of Pathology 2012;41(4):224-228
OBJECTIVETo study the clinicopathologic features of delayed radiation-induced brain injury after radiotherapy for brain tumor.
METHODSThe clinical, histopathologic and immunohistochemical features of 9 cases with delayed radiation-induced injury were evaluated.
RESULTSThe disease occurred from 6 months to 12 years after radiotherapy and often presented with headache and muscle weakness. Magnetic resonance imaging showed peripheral enhancing lesions with slight mass effect and surrounding edema. Microscopically, the major changes included coagulative necrosis, fibrinoid necrosis of vessels, vascular hyalinization with luminal stenosis and peripheral reactive gliosis. Immunostaining for hypoxia-inducible factors 1α was positive in reactive astrocytes.
CONCLUSIONSDelayed radiation-induced brain injury is a relatively common complication of radiation therapy. The lesion was frequently misdiagnosed as brain tumor. Correct diagnosis relies on clinical, radiologic and pathologic correlation.
Aged ; Brain Neoplasms ; radiotherapy ; Female ; Glioma ; radiotherapy ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit ; metabolism ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Radiation Injuries ; diagnosis ; diagnostic imaging ; metabolism ; pathology ; surgery ; Radiotherapy ; adverse effects ; Tomography, X-Ray Computed
8.Positron emission tomography with L-S-methyl-11C-methioine and its biodistribution.
Li-guang CHEN ; Mei-juan ZHOU ; An-wu TAN ; Shu-xia WANG ; Shan-zhen HE ; Zhen-hua DING
Journal of Southern Medical University 2007;27(6):834-835
OBJECTIVETo study the biodistribution of L-[S-methyl-(11)C]-methioine ((11)C-MET) and explore its clinical application in positron emission tomography (PET) for brain tumor detection.
METHODSTwenty-four Wistar rats and divided into 6 equal groups and injected with (11)C-MET through the tail vein and killed by decollation at 5, 10, 20, 30 and 40 min after injection, respectively. The liver, brain, blood, heart, lung, kidney, and spleen were harvested to measure the radioactivity and calculate the biodistribution of (11)C-MET. PET imaging with (11)C-MET was performed in 6 normal volunteers and 30 patients with pathologically confirmed brain gliomas.
RESULTS AND CONCLUSION(11)C-MET showed high blood uptake and a long retention in the tumor mass, therefore can be a valuable tracer for PET imaging of brain tumor and the hypophysis.
Adult ; Aged ; Animals ; Brain ; diagnostic imaging ; metabolism ; pathology ; Brain Neoplasms ; diagnosis ; diagnostic imaging ; metabolism ; Carbon Radioisotopes ; Female ; Glioma ; diagnosis ; diagnostic imaging ; metabolism ; Humans ; Injections, Intravenous ; Male ; Middle Aged ; Positron-Emission Tomography ; methods ; Radiopharmaceuticals ; administration & dosage ; pharmacokinetics ; Rats ; Rats, Wistar ; Sensitivity and Specificity ; Tissue Distribution ; Vitamin U ; administration & dosage ; pharmacokinetics
9.Molecular imaging of epidermal growth factor receptor in glioma-bearing rats.
Hui WANG ; Jin-Ming YU ; Xian-Rang SONG ; Guo-Ren YANG ; Dian-Bin MU ; Shu-Qiang ZHAO ; Xing-Wu WANG ; Ling WEI ; Yong-Lei LIU ; Bao SONG ; Zheng FU ; Xue-Peng TENG
Chinese Journal of Oncology 2008;30(5):343-346
OBJECTIVETo investigate the value of 11C-PD153035 as an EGFR imaging agent in C6 tumor-bearing rat.
METHODSThe tumor-bearing rats were generated by subcutaneous injection of glioma C6 cells. Positron emission tomography/computer tomography (PET/CT) scans started as soon as intravenous injection of 11C-PD153035 (15-20 MBq/0.3 ml) was completed, images were collected continuously. The region of interest (ROI) was used to study the percentage of radioactivity in major organs and implanted tumors in the rats. The accumulation and blocking study in vitro was completed.
RESULTSThere were significant differences in 11C-PD153035 uptake among major organs. The maximum uptake in the organs ranked in the following order: liver > gastrointestinal tract > kidney > lung > brain > muscle. Radioactivity could be also observed in the tumors. The radioactivity ratio (T/NT, target/non-target) peaked (4.15) at 40 - 50 min post injection. The in vitro blocking study showed that 11C-PD153035 uptaken by C6 cells could be blocked by PD153035.
CONCLUSIONThe results of this study show that 11C-PD153035 can be uptaken by EGFR-expressing tumors. 11C-PD153035 has a potential as a bioprobe to yield useful information for both diagnosis and therapy of tumors. However, the high concentration of 11C-PD153035 in the gastrointestinal tract is unfavorably affecting the tumor detection in these organs.
Animals ; Brain Neoplasms ; diagnostic imaging ; metabolism ; pathology ; Carbon Radioisotopes ; Cell Line, Tumor ; Gastrointestinal Tract ; metabolism ; Glioma ; diagnostic imaging ; metabolism ; pathology ; Liver ; metabolism ; Male ; Neoplasm Transplantation ; Positron-Emission Tomography ; Quinazolines ; pharmacokinetics ; Rats ; Rats, Wistar ; Receptor, Epidermal Growth Factor ; metabolism ; Tissue Distribution ; Tomography, X-Ray Computed
10.Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
Chinese Journal of Cancer 2011;30(8):574-580
Radioiodine is a routine therapy for differentiated thyroid cancers. Non-thyroid cancers can intake radioiodine after transfection of the human sodium iodide symporter (hNIS) gene. The human telomerase reverse transcriptase (hTERT) promoter, an excellent tumor-specific promoter, has potential value for targeted gene therapy of glioma. We used the hTERT promoter to drive the expression of the hNIS and human thyroid peroxidase (hTPO) gene as a primary step for testing the effects of radioiodine therapy on malignant glioma. The U87 and U251 cells were co-transfected with two adenoviral vectors, in which the hNIS gene had been coupled to the hTERT promoter and the hTPO gene had been coupled to the CMV promoter, respectively. Then, we performed Western blot, 125I intake and efflux assays, and clonogenic assay with cancer cells. We also did 99mTc tumor imaging of nude mice models. After co-transfection with Ad-hTERT-hNIS and Ad-CMV-hTPO, glioma cells showed the 125I intake almost 1.5 times higher than cells transfected with Ad-hTERT-hNIS alone. Western blots revealed bands of approximately 70 kDa and 110 kDa, consistent with the hNIS and hTPO proteins. In clonogenic assay, approximately 90% of co-transfected cells were killed, compared to 50% of control cells after incubated with 37 MBq of 131I. These results demonstrated that radioiodine therapy was effective in treating malignant glioma cell lines following induction of tumor-specific iodide intake by the hTERT promoter-directed hNIS expression in vitro. Co-transfected hNIS and hTPO genes can result in increased intake and longer retention of radioiodine. Nude mice harboring xenografts transfected with Ad-hTERT-NIS can take 99mTc scans.
Adenoviridae
;
genetics
;
Animals
;
Autoantigens
;
genetics
;
metabolism
;
Cell Line, Tumor
;
Cell Survival
;
Cytomegalovirus
;
genetics
;
Genetic Vectors
;
Glioma
;
diagnostic imaging
;
genetics
;
metabolism
;
pathology
;
Half-Life
;
Humans
;
Iodide Peroxidase
;
genetics
;
metabolism
;
Iodine Radioisotopes
;
metabolism
;
Iron-Binding Proteins
;
genetics
;
metabolism
;
Mice
;
Mice, Nude
;
Promoter Regions, Genetic
;
Recombinant Proteins
;
genetics
;
metabolism
;
Symporters
;
genetics
;
metabolism
;
Technetium
;
Telomerase
;
genetics
;
Tomography, Emission-Computed, Single-Photon
;
Transfection